Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3199453 | Journal of Allergy and Clinical Immunology | 2011 | 14 Pages |
Abstract
Selective loss of TH1/TH17 cells may be a risk factor for the development of active tuberculosis in patients with HIV-1 infection and might be a useful biomarker in the development of tuberculosis vaccines.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Sally MSc, Emma MB BS, Tom PhD, Rebecca PhD, Anton MD, Mark FRCP, Donald C. PhD, David FRCP, Frances PhD, Brian G. MD, Peter PhD,